Retail Clinics

WASHINGTON — A consumer education campaign launched by the National Consumers League and the U.S. surgeon general has received support from the drug retailing industry.

The National Association of Chain Drug Stores' charitable arm, the NACDS Foundation, engaged in the Script Your Future campaign and said it is the largest contributor to the campaign to date with its $1 million pledge.

WOONSOCKET, R.I. — CVS Caremark’s annual meeting of stockholders held Wednesday morning was an emotional and momentous occasion for the company as it marked the official retirement of Tom Ryan, former chairman and CEO, and the beginning of a new chapter as Larry Merlo takes the reigns as CEO.

ST. PAUL, Minn — A provider of simple and convenient online diagnosis and treatment of common health needs is broadening its reach.

Zipnosis said it will launch services in Colorado and Washington on May 15. Patients interested in having their symptoms reviewed and diagnosed can register at Zipnosis.com.

NEW YORK — The Food and Drug Administration expects to approve an increasing number of drugs, according to published reports.

Reuters quoted FDA Center for Drug Evaluation and Research director Janet Woodcock as saying the number of drugs approved gradually could increase, already having reached a “nadir.” The report noted that 12 drugs had won approval this year so far, and Woodcock speculated that the agency would approve more than the 21 it approved last year.

SWIFTWATER, Pa. — Sanofi’s vaccines division has won Food and Drug Administration approval for a vaccine designed for injection into the skin, the company said Tuesday.

Sanofi Pasteur announced the FDA approval of Fluzone Intradermal (influenza virus vaccine), which injects the vaccine into the skin via a short, fine needle, also known as a microinjection.

HORSHAM, Pa. — Patients with seasonal allergies are more likely to experience difficulty sleeping, according to results of a new survey conducted by Teva Respiratory.

ATLANTA — The number of people diagnosed with asthma in the United States grew by 4.3 million between 2001 and 2009, according to a new Vital Signs report released earlier this week by the Centers for Disease Control and Prevention.

In 2009, nearly 1-in-12 Americans were diagnosed with asthma. In addition to increased diagnoses, asthma costs grew from about $53 billion in 2002 to about $56 billion in 2007, representing a 6% increase. The explanation for the growth in asthma rates is unknown.

KANSAS CITY, Mo. — The blood test recommended for detecting Type 2 diabetes in overweight children may not be enough, and they may need two different tests to diagnose the disease, according to research conducted at Children's Mercy Hospital and Clinics in Kansas City, Mo.

The researchers found that the hemoglobin A1C test missed more than two-thirds of diabetes cases in children at high risk for the condition, but they found that performing that test along with the oral glucose tolerance test dramatically could lower the risk of delayed diagnosis in overweight children.